• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*FX25RW
Device Problem Break (1069)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/18/2020
Event Type  malfunction  
Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted occupation- technologist the actual device has not been returned for evaluation.The investigation is currently ongoing.A follow up report will be submitted once the investigation is complete.The product-release judgement record of the involved product code/lot# combination was conducted with no findings.(b)(4).
 
Event Description
The user facility reported that when they opened the capiox device sterilized package pre-treatment, there were no port caps on the blood inlet port.The perfusionist did not find the broken part in package.The patient was not harmed.
 
Manufacturer Narrative
The actual sample was received for evaluation and a photo was provided by the user facility.The picture of the actual sample during the event showed that the blood inlet port was fractured.The box in which the actual sample was packed at the time of arrival was confirmed that it was the box for the involved product code and lot# and, it was torn and crushed.From this state, it was not determined when the tear and the crush occurred.Visual inspection of the actual sample revealed that the blood inlet port had been fractured at the root.In addition, the water port and the gas port of the oxygenator had been deformed.No break, no deformity, or no other external anomaly was observed around the blood inlet port.The fractured blood inlet port was not returned for evaluation.The housing of the blood inlet port side was disassembled, then the root of the blood inlet port was inspected under magnifier.No crack, no deformity, or no other external anomaly was observed around the root of the blood inlet port.Magnifying inspection of the fractured section of the blood inlet port found that the fracture surface was smooth on the whole, and streaky pattern went out radially from the direction between the front side and the bottom side of the oxygenator.Magnifying inspection around the estimated central point of the radial streaky pattern found that wavy pattern went out from the same point.It was likely that an instantaneous load was exerted on the blood inlet port from the direction between the front side and the bottom side of the oxygenator.The fracture of the blood inlet port appeared to have started from the central point of the wavy pattern and developed radially.Review of the video that recorded the packing process of the involved product code/lot# combination confirmed that all the product of this lot had a blue cap attached to the blood inlet port.From this, it was conceivable that the blood inlet port of the actual sample was not fractured at the time of packing.Ifu states: do not use if the package or device is damaged (e.G.Cracked) or any of the port caps are off.Based on the provided information and investigation results, there is no definitive evidence that this event was related to a device defect or malfunction.It is likely that the blood inlet port was subjected to a shock load from the direction between the front side and the bottom side of the oxygenator and fractured.In addition, though the causal link with the fracture of the blood inlet port was unknown, the deformation of the water port and the gas port suggested that the actual sample was exposed to a shock load.Since no anomaly was noted in the manufacturing-related records or in the monitoring video in the packing process, it is likely that the actual sample was subjected to a shock load unexpectedly at some point during transportation or storage.However, the exact cause of the reported event cannot be definitively determined based on the available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX25 OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key11077356
MDR Text Key223801777
Report Number9681834-2020-00267
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350701046
UDI-Public04987350701046
Combination Product (y/n)N
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2023
Device Catalogue NumberCX*FX25RW
Device Lot Number200821C
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/05/2021
Initial Date Manufacturer Received 12/18/2020
Initial Date FDA Received12/28/2020
Supplement Dates Manufacturer Received01/05/2021
Supplement Dates FDA Received02/01/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-